Immediate H1N1 antiviral treatment for people in at-risk groups with flu symptoms is vital for saving lives, according to updated United Nations guidelines released today, calling for greater urgency than earlier recommendations.
A giant pharmaceutical company is slated to donate 50 million doses of the pandemic H1N1 vaccine to the United Nations public health arm, the World Health Organization (WHO) announced today.
The United Nations health agency today reiterated that countries need to remain prepared for the H1N1 virus, noting that the world has not yet hit the peak influenza season between January and February when more cases are expected.
![The H1N1 vaccine is being donated to developing nations [File Photo]](https://global.unitednations.entermediadb.net/assets/mediadb/services/module/asset/downloads/preset/assets/2009/09/09351/image100x100cropped.jpg "The H1N1 vaccine is being donated to developing nations [File Photo]")
![WHO staff prepare boxes of antiviral drugs to treat the H1N1 virus for dispatch to countries [File Photo]](https://global.unitednations.entermediadb.net/assets/mediadb/services/module/asset/downloads/preset/assets/2009/10/09535/image100x100cropped.jpg "WHO staff prepare boxes of antiviral drugs to treat the H1N1 virus for dispatch to countries [File Photo]")